UPDATED Apr 17, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IDIA | CHF1.82 | -2.2% | -80.8% | CHF325.5m | CHF1.72 | PS1.8x | E17.5% | n/a | Pharmaceuticals & Biotech | ||
CLTN | CHF53.00 | -6.7% | -33.1% | CHF316.7m | CHF62.00 | PE26.5x | E20.9% | 3.8% | Healthcare | ||
ASCN | CHF7.94 | -3.2% | -9.5% | CHF285.2m | CHF12.17 | PE16.4x | E12.9% | 3.8% | Healthcare | ||
KURN | CHF7.67 | -2.5% | 511.2% | CHF282.6m | n/a | PS8.4x | n/a | n/a | Pharmaceuticals & Biotech | ||
XLS | CHF34.20 | -7.6% | 10.3% | CHF195.1m | CHF68.00 | PE12.1x | E-142.7% | n/a | Pharmaceuticals & Biotech | ||
NWRN | CHF7.25 | -1.4% | 45.0% | CHF135.1m | CHF13.01 | PS15.4x | E53.3% | n/a | Pharmaceuticals & Biotech | ||
MOLN | CHF3.38 | -3.6% | -41.8% | CHF110.9m | CHF9.35 | PS15.8x | E5.1% | n/a | Pharmaceuticals & Biotech | ||
SANN | CHF9.85 | 5.0% | 53.9% | CHF90.8m | CHF30.00 | PS17.6x | S149.8% | n/a | Pharmaceuticals & Biotech | ||
SHLTN | CHF4.61 | -15.3% | -52.0% | CHF75.6m | n/a | PS1.5x | E43.8% | 0% | Healthcare | ||
ADXN | CHF0.19 | -4.1% | 62.6% | CHF26.3m | n/a | PS12.7x | E-4.1% | n/a | Pharmaceuticals & Biotech | ||
RLF | CHF1.22 | -6.5% | -82.9% | CHF15.2m | n/a | PS2.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
SPEX | CHF0.06 | -5.1% | -85.7% | CHF4.0m | n/a | PS3.5x | n/a | n/a | Pharmaceuticals & Biotech | ||
KNRS | CHF0.0036 | -10.0% | -64.0% | CHF3.9m | n/a | n/a | n/a | n/a | Pharmaceuticals & Biotech | ||
OBSN | CHF0.005 | -21.9% | -93.8% | CHF585.9k | n/a | PE0.08x | n/a | n/a | Pharmaceuticals & Biotech | ||
IGPH | CHF0.0015 | 200.0% | -96.9% | CHF505.5k | n/a | PE-0.05x | n/a | n/a | Healthcare | ||
ACHI | CHF0.0004 | 0% | -98.9% | CHF58.1k | n/a | PS2.6x | n/a | n/a | Pharmaceuticals & Biotech |